<

SANOFI-AVENTIS (EPA:SAN) Press Release: FDA accepts nirsevimab application as first protective option against RSV disease for all infants

Transparency directive : regulatory news

05/01/2023 08:00



Other stories

03/05/2024 11:40
03/05/2024 07:00
03/05/2024 08:55
03/05/2024 11:24
03/05/2024 11:06
03/05/2024 06:07
02/05/2024 07:21
03/05/2024 07:33
03/05/2024 11:45
02/05/2024 20:59
03/05/2024 00:36
02/05/2024 17:49
03/05/2024 10:43
02/05/2024 14:20
03/05/2024 11:53
03/05/2024 09:09
03/05/2024 08:21
03/05/2024 10:00
02/05/2024 18:17
02/05/2024 15:30
03/05/2024 01:03
03/05/2024 02:00
03/05/2024 10:08
03/05/2024 09:54
03/05/2024 10:34
03/05/2024 10:50
03/05/2024 09:14
03/05/2024 08:45
03/05/2024 11:01
03/05/2024 08:33
03/05/2024 11:33
01/05/2024 20:05
03/05/2024 10:15
02/05/2024 03:58
03/05/2024 03:30
03/05/2024 10:27
03/05/2024 07:46
02/05/2024 07:34